Aten Biotherapeutics LLC West Lafayette, IN - 47906

Aten Biotherapeutics LLC is categorized under Commercial Research Laboratory in West Lafayette, IN and active since 2012.

Aten Biotherapeutics LLC was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Research Laboratory business, which does work in the B2B market, and is classified as a Commercial Research Laboratory, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact David H Thompson at the company’s single location by writing to 230 Spring Valley Lane, West Lafayette, Indiana IN 47906 or by phoning (765) 746-5125. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Aten Biotherapeutics LLC
Contact Person: David H Thompson
Address: 230 Spring Valley Lane, West Lafayette, Indiana 47906
Phone Number: (765) 746-5125
Annual Revenue (USD): $50.000 to $99.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Research Laboratory
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Aten Biotherapeutics LLC was started in 2012 to provide professional Commercial Research Laboratory under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact David H Thompson for inquiries that concern Aten Biotherapeutics LLC by calling the company number (765) 746-5125, as your correspondence is most welcome. Additionally, the physical location of the single location of Aten Biotherapeutics LLC can be found at the coordinates 40.418219,-86.99029 as well as the street address 230 Spring Valley Lane in West Lafayette, Indiana 47906.

For its online presence, you may visit Aten Biotherapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.